List of Tables
    Table 1. β Adrenoceptor Agonists Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. β Adrenoceptor Agonists Market Trends
    Table 3. β Adrenoceptor Agonists Market Drivers
    Table 4. β Adrenoceptor Agonists Market Challenges
    Table 5. β Adrenoceptor Agonists Market Restraints
    Table 6. Global β Adrenoceptor Agonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States β Adrenoceptor Agonists Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global β Adrenoceptor Agonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States β Adrenoceptor Agonists Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top β Adrenoceptor Agonists Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global β Adrenoceptor Agonists Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global β Adrenoceptor Agonists Revenue Share by Player, 2017-2022
    Table 13. Global β Adrenoceptor Agonists Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global β Adrenoceptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β Adrenoceptor Agonists as of 2021)
    Table 15. Top Players of β Adrenoceptor Agonists in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into β Adrenoceptor Agonists Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top β Adrenoceptor Agonists Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States β Adrenoceptor Agonists Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States β Adrenoceptor Agonists Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global β Adrenoceptor Agonists Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global β Adrenoceptor Agonists Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global β Adrenoceptor Agonists Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America β Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific β Adrenoceptor Agonists Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe β Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa β Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa β Adrenoceptor Agonists Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Ivax Pharmaceuticals  Company Details
    Table 31. Ivax Pharmaceuticals  Business Overview
    Table 32. Ivax Pharmaceuticals  β Adrenoceptor Agonists Product
    Table 33. Ivax Pharmaceuticals  Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 34. Ivax Pharmaceuticals  Recent Development
    Table 35. Physicians Total Care Company Details
    Table 36. Physicians Total Care Business Overview
    Table 37. Physicians Total Care β Adrenoceptor Agonists Product
    Table 38. Physicians Total Care Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 39. Physicians Total Care Recent Development
    Table 40. Baxter Healthcare  Company Details
    Table 41. Baxter Healthcare  Business Overview
    Table 42. Baxter Healthcare  β Adrenoceptor Agonists Product
    Table 43. Baxter Healthcare  Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 44. Baxter Healthcare  Recent Development
    Table 45. Sanofi Company Details
    Table 46. Sanofi Business Overview
    Table 47. Sanofi β Adrenoceptor Agonists Product
    Table 48. Sanofi Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 49. Sanofi Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer β Adrenoceptor Agonists Product
    Table 53. Pfizer Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Bedford Laboratories Company Details
    Table 56. Bedford Laboratories Business Overview
    Table 57. Bedford Laboratories β Adrenoceptor Agonists Product
    Table 58. Bedford Laboratories Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 59. Bedford Laboratories Recent Development
    Table 60. Novartis Company Details
    Table 61. Novartis Business Overview
    Table 62. Novartis β Adrenoceptor Agonists Product
    Table 63. Novartis Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. Sterimax Company Details
    Table 66. Sterimax Business Overview
    Table 67. Sterimax β Adrenoceptor Agonists Product
    Table 68. Sterimax Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 69. Sterimax Recent Development
    Table 70. Teligent Company Details
    Table 71. Teligent Business Overview
    Table 72. Teligent β Adrenoceptor Agonists Product
    Table 73. Teligent Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 74. Teligent Recent Development
    Table 75. AstraZeneca Company Details
    Table 76. AstraZeneca Business Overview
    Table 77. AstraZeneca β Adrenoceptor Agonists Product
    Table 78. AstraZeneca Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 79. AstraZeneca Recent Development
    Table 80. Hikma Pharmaceuticals Company Details
    Table 81. Hikma Pharmaceuticals Business Overview
    Table 82. Hikma Pharmaceuticals β Adrenoceptor Agonists Product
    Table 83. Hikma Pharmaceuticals Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 84. Hikma Pharmaceuticals Recent Development
    Table 85. Av Kare Company Details
    Table 86. Av Kare Business Overview
    Table 87. Av Kare β Adrenoceptor Agonists Product
    Table 88. Av Kare Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 89. Av Kare Recent Development
    Table 90. Impax Laboratories Company Details
    Table 91. Impax Laboratories Business Overview
    Table 92. Impax Laboratories β Adrenoceptor Agonists Product
    Table 93. Impax Laboratories Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 94. Impax Laboratories Recent Development
    Table 95. PD-Rx Pharmaceuticals Company Details
    Table 96. PD-Rx Pharmaceuticals Business Overview
    Table 97. PD-Rx Pharmaceuticals β Adrenoceptor Agonists Product
    Table 98. PD-Rx Pharmaceuticals Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 99. PD-Rx Pharmaceuticals Recent Development
    Table 100. Athenex Pharmaceutical Division Company Details
    Table 101. Athenex Pharmaceutical Division Business Overview
    Table 102. Athenex Pharmaceutical Division β Adrenoceptor Agonists Product
    Table 103. Athenex Pharmaceutical Division Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 104. Athenex Pharmaceutical Division Recent Development
    Table 105. Teva Company Details
    Table 106. Teva Business Overview
    Table 107. Teva β Adrenoceptor Agonists Product
    Table 108. Teva Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 109. Teva Recent Development
    Table 110. Marlex Pharmaceuticals Company Details
    Table 111. Marlex Pharmaceuticals Business Overview
    Table 112. Marlex Pharmaceuticals β Adrenoceptor Agonists Product
    Table 113. Marlex Pharmaceuticals Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 114. Marlex Pharmaceuticals Recent Development
    Table 115. Lannett Company Company Details
    Table 116. Lannett Company Business Overview
    Table 117. Lannett Company β Adrenoceptor Agonists Product
    Table 118. Lannett Company Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 119. Lannett Company Recent Development
    Table 120. West-Ward Pharmaceuticals Company Details
    Table 121. West-Ward Pharmaceuticals Business Overview
    Table 122. West-Ward Pharmaceuticals β Adrenoceptor Agonists Product
    Table 123. West-Ward Pharmaceuticals Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 124. West-Ward Pharmaceuticals Recent Development
    Table 125. United Biomedical Company Details
    Table 126. United Biomedical Business Overview
    Table 127. United Biomedical β Adrenoceptor Agonists Product
    Table 128. United Biomedical Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 129. United Biomedical Recent Development
    Table 130. Merck Company Details
    Table 131. Merck Business Overview
    Table 132. Merck β Adrenoceptor Agonists Product
    Table 133. Merck Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 134. Merck Recent Development
    Table 135. Mylan Company Details
    Table 136. Mylan Business Overview
    Table 137. Mylan β Adrenoceptor Agonists Product
    Table 138. Mylan Revenue in β Adrenoceptor Agonists Business (2017-2022) & (US$ Million)
    Table 139. Mylan Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. β Adrenoceptor Agonists Product Picture
    Figure 2. Global β Adrenoceptor Agonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global β Adrenoceptor Agonists Market Size 2017-2028 (US$ Million)
    Figure 4. United States β Adrenoceptor Agonists Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States β Adrenoceptor Agonists Market Size 2017-2028 (US$ Million)
    Figure 6. United States β Adrenoceptor Agonists Market Share in Global 2017-2028
    Figure 7. β Adrenoceptor Agonists Report Years Considered
    Figure 8. Product Picture of Isoprenaline
    Figure 9. Product Picture of Dobutamine
    Figure 10. Product Picture of Salbutamol
    Figure 11. Product Picture of Terbutaline
    Figure 12. Product Picture of Salmeterol
    Figure 13. Product Picture of Formoterol
    Figure 14. Product Picture of Pirbuterol
    Figure 15. Global β Adrenoceptor Agonists Market Share by Type in 2022 & 2028
    Figure 16. Global β Adrenoceptor Agonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global β Adrenoceptor Agonists Market Share by Type (2017-2028)
    Figure 18. United States β Adrenoceptor Agonists Market Share by Type in 2022 & 2028
    Figure 19. United States β Adrenoceptor Agonists Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States β Adrenoceptor Agonists Market Share by Type (2017-2028)
    Figure 21. Product Picture of Chronic Heart Failure
    Figure 22. Product Picture of Myocardial Infarction
    Figure 23. Product Picture of Postoperative Hypotension
    Figure 24. Product Picture of Bronchial Asthma
    Figure 25. Product Picture of Asthmatic Bronchitis
    Figure 26. Product Picture of Emphysema
    Figure 27. Product Picture of Others
    Figure 28. Global β Adrenoceptor Agonists Market Share by Application in 2022 & 2028
    Figure 29. Global β Adrenoceptor Agonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. Global β Adrenoceptor Agonists Market Share by Application (2017-2028)
    Figure 31. United States β Adrenoceptor Agonists Market Share by Application in 2022 & 2028
    Figure 32. United States β Adrenoceptor Agonists Market Size by Application (2017-2028) & (US$ Million)
    Figure 33. United States β Adrenoceptor Agonists Market Share by Application (2017-2028)
    Figure 34. North America β Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. U.S. β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Canada β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Europe β Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. Germany β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. France β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. U.K. β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Italy β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Russia β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Asia-Pacific β Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 44. China β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Japan β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. South Korea β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. India β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Australia β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Taiwan β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Indonesia β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Thailand β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Malaysia β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Philippines β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Latin America β Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Mexico β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Brazil β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Argentina β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Middle East & Africa β Adrenoceptor Agonists Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 59. Turkey β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Saudi Arabia β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 61. U.A.E β Adrenoceptor Agonists Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Ivax Pharmaceuticals  Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 63. Physicians Total Care Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 64. Baxter Healthcare  Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 65. Sanofi Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 66. Pfizer Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 67. Bedford Laboratories Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 68. Novartis Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 69. Sterimax Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 70. Teligent Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 71. AstraZeneca Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 72. Hikma Pharmaceuticals Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 73. Av Kare Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 74. Impax Laboratories Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 75. PD-Rx Pharmaceuticals Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 76. Athenex Pharmaceutical Division Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 77. Teva Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 78. Marlex Pharmaceuticals Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 79. Lannett Company Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 80. West-Ward Pharmaceuticals Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 81. United Biomedical Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 82. Merck Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 83. Mylan Revenue Growth Rate in β Adrenoceptor Agonists Business (2017-2022)
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed